Indian Pharmaceutical Alliance

Association representing research-based national pharmaceutical companies.

🤖

AI Overview

With $0 in lobbying spend across 6 quarterly filings, Indian Pharmaceutical Alliance is an active lobbying client. Their lobbying covers 1 issue area. Active from 2019 to 2020.

$0
Total Spend
2
Years Active
1
Firms Hired
2
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2019$0
2020$0

Issues Lobbied

Lobbying Firms

Lobbyists

Government Agencies Targeted

These are the government entities that Indian Pharmaceutical Alliance disclosed contacting in their lobbying filings.

Health & Human Services, Dept of (HHS)HOUSE OF REPRESENTATIVESSENATEU.S. Trade Representative (USTR)Centers For Medicare and Medicaid Services (CMS)Federal Trade Commission (FTC)Food & Drug Administration (FDA)
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Trade

Trade issues related to generic medicines and biosimilars.

Trade related to generic medicines and biosimilars.

Trade related to generic medicines and biosimilars.

H.R. 938, BLOCKING Act of 2019.

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.